Journals / Endokrinolojide Diyalog Dergisi / 2012 / Cilt: 9 - Sayı: 4

Kemik metastazları ile başvuran bir paratiroid karsinoma vakası: Literatürün gözden geçirilmesi

A case of parathyroid carcinoma presenting with bone metastasis: Brief review of the literature

Pages
196–201
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RT is the second line treatment in the case of recurrent disease or metastasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Parathyroid carcinoma (PC) is an uncommon malignancy and rare cause of primary hyperparathyroidism.
📊
Key Findings & Data:Case: A 56-year-old female was admitted with the complaint of bone pain on the right side of the pelvis.
💡
Conclusion & Impact:RT is the second line treatment in the case of recurrent disease or metastasis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Parathyroid carcinoma (PC) is an uncommon malignancy and rare cause of primary hyperparathyroidism. Hypercalcemia caused by PC frequently leads to metabolic bone disease and renal complications with a high morbidity. Local cervical invasion, spread to cervical lymph nodes and lung and bone metastasis are frequently seen. Case: A 56-year-old female was admitted with the complaint of bone pain on the right side of the pelvis. On clinical examination, a nontender mass was palpated on the left side of the neck. Pelvis X-ray revealed a suspected fracture line on the right side. The laboratory investigations revealed as Ca:15,5 mg/dl, P: 2,1 mg/dl and intact PTH: 880,2 pg/ml. Neck ultrasound and Tc-99m MIBI scan revealed parathyroid adenoma. MRI and MIBI detected multiple bone lesions suspected as metastases. PET/CT was performed to clarify the presence of metastasis. Parathyroidectomy was performed. Pathological examination showed parathyroid carcinoma. Hungry bone syndrome after the surgical procedure was developed and Ca replacement was given. Radiotherapy (RT) was applied for bone metastases. PC is a rare but aggressive malignant disease with high recurrence rates and mortality. Surgery is the main treatment for PC. If there is a preoperative suspicion for PC, more aggressive excision should be preferred which may cause a higher cure rate. High serum Ca, PTH levels and palpable neck mass should alert the clinician for malignancy. Hypocalcemia crisis (hungry bone syndrome) is frequently expected after the surgery so patient should be monitorized for serum Ca levels. RT is the second line treatment in the case of recurrent disease or metastasis.

Özet

Primer hiperparatiroidinin (PHP) en nadir nedenlerinden olan paratiroid karsinom (PK) (

🔖

Cite This Article

TUĞRUL, A., GÜLDİKEN, S., ALTUN, B. U., TORUN, N., ATİLE, N. S., BİLİR, B. E., ÇALIK, A., SEZER, A. (2022). Kemik metastazları ile başvuran bir paratiroid karsinoma vakası: Literatürün gözden geçirilmesi. Endokrinolojide Diyalog Dergisi, Cilt: 9 - Sayı: 4, 196–201. https://ajindex.com/articles/500725

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Lee JE. Predicting the presence of parathyroid carcinoma. Ann Surg Oncol 2005;12:513-514
  2. Lee PK, Jarosek SL, Vimig BA et al. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 2007:109;1736-1741
  3. Ruda JM; Hollenbeak CS; Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132(3):359-372
  4. Dudney WC, Bodenner D, Stack BC Jr. Parathyroid carcinoma. Otolaryngol Clin North Am 2010;43(2):441-453
  5. Shane, E. Parathyroid carcinoma. J Clin Endocrinol Metab 2001;86:485-493
  6. Abdelgadir Adam M, Untch BR, Olson JA Jr. Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics. Oncologist 2010;15(1):61-72
  7. Sharretts JM, Kebebew E, Simonds WF. Parathyroid cancer. Semin Oncol 2010;37(6):580-590
  8. Teh BT, Farnebo F, Twigg S, et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 1998;83(6):2114-2120
  9. Carpten JD, Robbins CM, Villablanca A, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002;32(4):676-680
  10. Szabo J, Heath B, Hill VM, et al. Hereditary hyperparathyroidism- jaw tunor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 1995;56:944-950
  11. Talat N, Schulte KM. Clinical presentation, staging and longterm evolution of parathyroid cancer. Ann Surg Oncol 2010;17(8):2156-2174
  12. Givi B, Shah JP. Parathyroid carcinoma. Clin Oncol (R Coll Radiol) 2010;22(6):498-507
  13. Iihara M, Okamoto T, Suzuki R, et al. Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis. Surgery 2007;142(6):936-943
  14. Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg 2007;94(5):566-570
  15. Cordeiro AC, Montenegro FL, Kulcsar MA, et al. Parathyroid carcinoma. Am J Surg 1998;175(1):52-55
  16. Agarwal G, Dhingra S, Mishra SK et al. Imlantation of parathyroid carcinoma along fine needle aspiration tract. Langenbecks Arch Surg 2006;391:623-626
  17. Robert JH, Trombetti A, Garcia A, et al. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature.